Association of metabolic risk factors with uncontrolled hypertension: Comparison of the several definitions of metabolic syndrome

Journal of Hypertension

Volumn 31, Issue 10, 2013, Pages 1991-1997

  Cortez Dias, Nuno ^a,b,c   Martins, Susana R ^a,b   Belo, Adriana ^d   Fiuza, Manuela ^a,b  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c Ministerio da Saude Portuguese   (Portugal)

^d Biostatistics Department   (Portugal)

Author keywords

Abdominal obesity; Antihypertensive; Hypertension; Metabolic syndrome X; Obesity; Primary healthcare; Treatment effectiveness

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY COMPOSITION; CARDIOLOGY; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OBESITY, ABDOMINAL; ODDS RATIO; OUTPATIENTS; PORTUGAL; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84884419359     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836342f7     Document Type: Article

References (31)

1. Rodgers A, Ezzati M, Vander HS, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med 2004; 1:e27.
2. Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761-2788.
3. DiTusa L, Luzier AB, Jarosz DE, Snyder BD, Izzo JL Jr. Treatment of hypertension in a managed care setting.Am J Manag Care 2001; 7:520-524.
4. Pittrow D, Kirch W, Bramlage P, Lehnert H, Hofler M, Unger T, et al. Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol 2004; 60:135-142.
5. Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 2004; 117:14-18.
6. Redon J, Cea-Calvo L, Lozano JV, Marti-Canales JC, Llisterri JL, Aznar J, et al. Differences in blood pressure control and stroke mortality across Spain: the Prevencion de Riesgo de Ictus (PREV-ICTUS) study. Hypertension 2007; 49:799-805.
7. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49:403-414.
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
9. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-438.
10. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet 2005; 366:1059-1062.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
12. de Marco M, de Simone G, Roman MJ, Chinali M, Lee ET, Russell M, et al. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009; 54:974-980.
13. Romero R, Bonet J, de la SA, Aguilera MT, Investigators OB. Undiagnosed obesity in hypertension: clinical and therapeutic implications. Blood Press 2007; 16:347-353.
14. Arcucci O, de Simone G, Izzo R, Rozza F, Chinali M, Rao MA, et al. Association of suboptimal blood pressure control with body size and metabolic abnormalities. J Hypertens 2007; 25:2296-2300.
15. Bog-Hansen E, Lindblad U, Gullberg B, Melander A, Rastam L. Metabolic disorders associated with uncontrolled hypertension. Diabetes Obes Metab 2003; 5:379-387.
16. Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 2004; 17:904-910.
17. Zidek W, Naditch-Brule L, Perlini S, Farsang C, Kjeldsen SE. Blood pressure control and components of the metabolic syndrome: the GOOD survey. Cardiovasc Diabetol 2009; 8:51.
18. Kjeldsen SE, Naditch-Brule L, Perlini S, Zidek W, Farsang C. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens 2008; 26:2064-2070.
19. de Marco M, de Simone G, Izzo R, Mancusi C, Sforza A, Giudice R, et al. Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors. J Hypertens 2012; 30:188-193.
20. Cortez-Dias N, Martins S, Belo A, Fiuza M. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Rev Port Cardiol 2009; 28:499-523.
21. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-1727.
22. Sardinha LB, Santos DA, Silva AM, Coelho-e-Silva MJ, Raimundo AM, Moreira H, et al. Prevalence of overweight, obesity, and abdominal obesity in a representative sample of Portuguese adults. PLoS One 2012; 7:e47883.
23. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens 1994; 12:1433-1437.
24. Hu FB, Wang B, Chen C, Jin Y, Yang J, Stampfer MJ, Xu X. Body mass index and cardiovascular risk factors in a rural Chinese population. Am J Epidemiol 2000; 151:88-97.
25. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16:235-251.
26. Vyssoulis GP, Karpanou EA, Liakos CI, Kyvelou SM, Tzamou VE, Michaelides AP, et al. Cardiovascular risk factor(s) prevalence in Greek hypertensives. Effect of gender and age. J Hum Hypertens 2012; 26:443-451.
27. Egan BM, Papademetriou V, Wofford M, Calhoun D, Fernandes J, Riehle JE, et al. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Am J Hypertens 2005; 18:3-12.
28. Vazquez VA, Vazquez CA, Calderin RO, Buchaca EF, Cruz Alvarez NM, Jimenez PR, et al. [Metabolic syndrome in patients with essential hypertension]. Nefrologia 2003; 23:423-431.
29. Yanai H, Tomono Y, Ito K, Furutani N, Yoshida H, Tada N. The underlying mechanisms for development of hypertension in the metabolic syndrome. Nutr J 2008; 7:10.
30. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26:3160-3167.
31. Cortez-Dias N, Martins S, Belo A, Fiuza M. Comparison of definitions of metabolic syndrome in relation to risk for coronary artery disease and stroke. Rev Port Cardiol 2011; 30:139-169.